| Key Financial Ratios of Sharon Bio Medicine (in Rs. Cr.) |
Mar 23 |
Mar 22 |
Mar 21 |
Mar 20 |
Mar 19 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
33.02 |
30.71 |
24.41 |
1.42 |
0.96 |
|
| Diluted EPS (Rs.) |
33.02 |
30.71 |
24.41 |
1.42 |
0.96 |
|
| Cash EPS (Rs.) |
51.69 |
50.22 |
44.41 |
2.35 |
1.89 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
-1,025.70 |
-1,058.50 |
-1,086.73 |
-53.79 |
-52.50 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
-1,025.70 |
-1,058.50 |
-1,086.73 |
-53.79 |
-52.50 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
338.77 |
327.32 |
300.34 |
14.40 |
12.16 |
|
| PBDIT/Share (Rs.) |
51.79 |
50.41 |
44.71 |
2.37 |
1.98 |
|
| PBIT/Share (Rs.) |
33.13 |
30.90 |
24.71 |
1.44 |
1.04 |
|
| PBT/Share (Rs.) |
33.02 |
30.71 |
24.41 |
1.42 |
0.95 |
|
| Net Profit/Share (Rs.) |
33.02 |
30.71 |
24.41 |
1.42 |
0.95 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
15.28 |
15.40 |
14.88 |
16.46 |
16.26 |
|
| PBIT Margin (%) |
9.77 |
9.44 |
8.22 |
10.00 |
8.54 |
|
| PBT Margin (%) |
9.74 |
9.38 |
8.12 |
9.87 |
7.78 |
|
| Net Profit Margin (%) |
9.74 |
9.38 |
8.12 |
9.87 |
7.78 |
|
| Return on Networth / Equity (%) |
-3.21 |
-2.90 |
-2.24 |
-2.64 |
-1.80 |
|
| Return on Capital Employed (%) |
-73.23 |
-40.66 |
-23.33 |
-22.37 |
-19.38 |
|
| Return on Assets (%) |
6.07 |
5.90 |
4.84 |
6.11 |
4.20 |
|
| Total Debt/Equity (X) |
-1.40 |
-1.36 |
-1.32 |
-1.29 |
-1.32 |
|
| Asset Turnover Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.52 |
0.45 |
0.40 |
0.34 |
0.24 |
|
| Quick Ratio (X) |
0.40 |
0.33 |
0.26 |
0.22 |
0.15 |
|
| Inventory Turnover Ratio (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EV/Net Operating Revenue (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/Net Operating Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Yield |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
